Experts in Dengue Control Form New Alliance to Bridge Vaccine and Vector Approaches and Expand Efforts to Zika and other Aedes-Transmitted Diseases

Mexico City, Mexico – August 31, 2016 – Today, four leading institutions at the forefront of dengue prevention and control—the International Vaccine Institute (IVI), the International Vaccine Access Center (IVAC) of the Johns Hopkins University, the Partnership for Dengue Control Foundation (PDC) and the Sabin Vaccine Institute—announced a new global alliance to integrate approaches to fight dengue and other Aedes-transmitted diseases under one strategic umbrella. Named the Global Dengue and Aedes-transmitted Diseases Consortium (GDAC), this new partnership will expand its expertise in dengue to other Aedes-transmitted diseases including Zika, chikungunya and yellow fever, responding to the urgent need for coordination in the currently fragmented efforts to control the diseases transmitted by one of the world's most dangerous animals—the Aedes mosquito.
Every year from July to September across South Asia, the monsoon ushers in rain that boosts the growth of crops and powers the hydroelectric dams. While these annual rains help the economy, their torrential nature often hurts the health of vulnerable communities through dangerous flooding across the region.

Sabin Vaccine Institute Awarded Funding to Advance Country Ownership of Immunization

WASHINGTON, D.C. — August 25, 2016 — The Sabin Vaccine Institute announced today that it has received an award of US$468,328 from the U.S. Centers for Disease Control and Prevention (CDC) to support initiatives to improve sustainable immunization financing. The project, conducted in partnership with the Pan American Health Organization (PAHO), will support sustainable financing, planning and decision-making for immunization programs in low- and middle-income countries. The program will launch in the Democratic Republic of Congo, Senegal and Kenya in 2016.
Last month, the Sabin Vaccine Institute gathered 126 representatives from 17 countries for the Third Colloquium on Sustainable Immunization Financing. Members of Parliament, officials from Ministries of Health, Finance and other national and subnational ministries, and international partners joined to exchange ideas and experiences in developing innovative, long-term financing solutions for immunization.
Mike McQuestion, Ph.D., M.P.H., served as Director of Sabin's Sustainable Immunization Financing program from 2007-2016. Prior to his work with Sabin, Dr.

Countries Showcase Innovations for Sustainable Funding of Immunization at Kathmandu Conference

KATHMANDU, NEPAL — July 19, 2016 — The Sabin Vaccine Institute’s Sustainable Immunization Financing (SIF) Program today assembled senior officials from 21 countries to share their successes in increasing government budget allocations for national immunization programs. Greater political commitment and advocacy are building the momentum needed for countries to fully finance their immunization programs by 2020 and achieve the goals set forth in the Global Vaccine Action Plan (GVAP).

Pages

Subscribe to RSS - Vaccine Advocacy and Education